# Use of Antioxidant in Endometriotic Women to Improve Intracytoplasmic Sperm Injection (ICSI)

> **NCT02058212** · PHASE2 · COMPLETED · sponsor: **Cairo University** · enrollment: 50 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** ascorbate 1000mg, vitamin E 400, zinc and selenium

## Key facts

- **NCT ID:** NCT02058212
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-10
- **Final completion:** 2013-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02058212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02058212, "Use of Antioxidant in Endometriotic Women to Improve Intracytoplasmic Sperm Injection (ICSI)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02058212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*